Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.9277
+0.0154 (1.69%)
Aug 19, 2026, 12:52 PM EDT - Market open
Bio Green Med Solution Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.86 | 0.75 | 0.04 | 0.42 | - | - | |
Revenue Growth | 18510.00% | 1637.21% | -89.76% | - | - | - |
Cost of Revenue | 2.25 | 1.42 | 6.56 | 18.72 | - | - |
Gross Profit | -0.39 | -0.67 | -6.52 | -18.3 | - | - |
Selling, General & Admin | 3.14 | 7.72 | 5.39 | 6.72 | 7.38 | 7.46 |
Research & Development | 0.03 | 0.04 | 0.09 | 0.43 | 20.27 | 14.93 |
Operating Expenses | 3.17 | 7.75 | 5.49 | 7.15 | 27.66 | 22.39 |
Operating Income | -3.56 | -8.43 | -12 | -25.45 | -27.66 | -22.39 |
Interest & Investment Income | 0.07 | 0.06 | 0.01 | 0.27 | 0.21 | 0.02 |
Currency Exchange Gain (Loss) | 0.11 | 0.07 | -0.05 | -0.41 | 0.23 | 0.04 |
Other Non Operating Income (Expenses) | 0.4 | 0.35 | 0.05 | 0.05 | 1.3 | 0.14 |
EBT Excluding Unusual Items | -2.98 | -7.94 | -11.99 | -25.55 | -25.92 | -22.19 |
Gain (Loss) on Sale of Assets | 4.95 | 4.95 | - | - | - | - |
Pretax Income | 1.97 | -2.99 | -11.99 | -25.55 | -25.92 | -22.19 |
Income Tax Expense | 0.04 | 0.01 | -0.78 | -3 | -4.72 | -3.73 |
Net Income | -2.2 | -3 | -11.21 | -22.56 | -21.2 | -18.46 |
Preferred Dividends & Other Adjustments | 11.11 | 11.09 | - | 0.2 | 0.2 | 0.2 |
Net Income to Common | -13.32 | -14.09 | -11.21 | -22.76 | -21.4 | -18.66 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 5 | 2 | 0 | - | - | - |
Shares Outstanding (Diluted) | 5 | 2 | 0 | - | - | - |
Shares Change | 184.82% | 9692.40% | - | - | - | - |
EPS (Basic) | -2.95 | -6.45 | -502.46 | - | - | - |
EPS (Diluted) | -2.95 | -6.45 | -502.46 | - | - | - |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | - | -4.77 | -7.99 | -16.12 | -20.83 | -18.57 |
Free Cash Flow Per Share | - | -2.18 | -358.07 | - | - | - |
Gross Margin | -20.85% | -90.09% | - | - | - | - |
Operating Margin | -191.29% | -1128.11% | -27916.28% | -6060.24% | - | - |
Profit Margin | -715.48% | -1886.48% | -26074.42% | -5418.10% | - | - |
Free Cash Flow Margin | - | -638.55% | -18581.40% | -3837.62% | - | - |
EBITDA | -3.55 | -8.42 | -12 | -25.42 | -27.62 | -22.35 |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
EBIT | -3.56 | -8.43 | -12 | -25.45 | -27.66 | -22.39 |
Revenue as Reported | 1.86 | 0.75 | 0.04 | 0.42 | - | - |